From: Anti-dementia drugs and changes in gait: a pre-post quasi-experimental pilot study
Change in CoV of stride time* | ||||||
---|---|---|---|---|---|---|
Model 1† | Model 2† | |||||
β | 95% CI | P-value | β | 95% CI | P-value | |
Drugs effect | ||||||
Use of CEIs | −0.067 | [−0.381; 0.246] | 0.674 | −0.193 | [−0.512; 0.125] | 0.234 |
Use of memantine | 0.179 | [−0.138; 0.496] | 0.268 | −0.014 | [−0.341; 0.313] | 0.933 |
Time effect‡ | 0.019 | [−0.232; 0.269] | 0.885 | 0.019 | [−0.222; 0.259] | 0.878 |
Drugs x time interaction | ||||||
No treatment | Ref | Ref | ||||
Use of CEIs | 0.186 | [−0.153; 0.526] | 0.282 | 0.190 | [−0.138; 0.518] | 0.256 |
Use of memantine | −0.385 | [−0.728; -0.415] | 0.028 | −0.371 | [−0.702; -0.041] | 0.028 |
Age | 0.000 | [−0.000; 0.000] | 0.811 | |||
Female gender | −0.229 | [−0.453; -0.004] | 0.046 | |||
BMI | −0.0004 | [−0.0000; 0.0008] | 0.053 | |||
Number of drugs daily taken¶ | 0.011 | [−0.019; 0.041] | 0.490 | |||
Use of psychoactive drugs#¶ | 0.081 | [−0.278; 0.116] | 0.422 | |||
MMSE score¶ | −0.028 | [−0.046; -0.009] | 0.003 | |||
Walking speed¶ | −0.003 | [−0.006; 0.0001] | 0.147 |